BactiQuant A/S

As of June 30, 2026, BactiQuant A/S carries a market capitalization of 93.80M, placing it among publicly traded companies globally. Its enterprise value stands at 89.99M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, BactiQuant A/S has 37.52M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, BactiQuant A/S maintains a current ratio of 5.20, meaning it holds 5.2x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, BactiQuant A/S's stock has gained approximately 4.09% over the past 52 weeks. The 50-day moving average sits at 2.21, while the 200-day moving average is 2.74.

As of June 30, 2026, BactiQuant A/S holds 11.94M in cash and equivalents against 8.13M in total debt, resulting in a net debt position of -4.01M. Total book value stands at 12.48M, with working capital of 14.86M providing operational flexibility.

BactiQuant A/S's most recent stock split took place on January 13, 2025 with a 241:270 split ratio.